Engineer 1 - Development at Illumina

San Diego, California, United States

Illumina Logo
$67,000 – $100,600Compensation
Entry Level & New Grad, Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Genomics, Medical DevicesIndustries

Requirements

  • Bachelor of Science Degree in a STEM discipline (Engineering, Math, Science, Technology)
  • Proficiency in programming tools, such as Matlab and LabVIEW
  • Experience with real time test environments such as National Instruments
  • Good verbal and written skills required
  • Strong troubleshooting skills

Responsibilities

  • Develop plans, procedures and execute engineering verification for Instrument modules like Optics, mechanical and thermal
  • Develop plans, procedures and execute robustness testing like environmental corner case and shipping/vibration
  • Develop custom test scripts to support CPM and design verification activities
  • Develop test setups to support CPM and life tests
  • Create and present test findings to the cross functional design teams
  • Create concise reports that document test results, requirement verification and limitations and constraints
  • Support system- and subsystem-level integration and test, including any 8D investigations
  • Contribute as a key technical member on a team of creative, independent individuals

Skills

Matlab
LabVIEW
National Instruments
Optics
Mechanical Engineering
Thermal Testing
Test Scripting
Troubleshooting
Environmental Testing
Vibration Testing

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI